|
Market Closed -
Other stock markets
|
After hours 22:59:59 | |||
| 0.6980 EUR | +36.59% |
|
0.6910 | -1.00% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.645 | 0.898 | 0.895 |
| Spread/Res. | +8.22% | -22.27% | -22.01% |
| Spread/Supp. | +49.15% | +79.43% | +52.07% |
| Support | 0.468 | 0.389 | 0.459 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
Select your edition
All financial news and data tailored to specific country editions
